News
-
Open position: QA/RA Director / Avoin työpaikka: Laatu- ja regulaatiojohtaja
31.3.2021
We are looking for a QA/RA Director. Position requires fluent Finnish.
Toimintamme voimakkaasti kasvaessa etsimme joukkoomme laatu- ja regulaatiojohtajaa.
Työpaikkailmoitus -
New assay for rapid detection of SARS-CoV-2 variant strains now available for research use!
22.3.2021
Abacus Diagnostica has developed a SARS-CoV-2 Variants of Concern (VoC) Assay for the GenomEra® CDX platform. In addition to detecting all SARS-CoV-2 strains, the new test detects clinically significant deletions present in the variants first identified in the UK (B.1.1.7), South Africa (B.1.351), and Brazil (P.1). The test is now available as a Research Use Only -product.
-
GenomEra® multiplex assay is now CE marked and available!
18.12.2020
For inquiries, please contact info@abacusdiagnostica.com
-
Two open positions: Application / Service Engineer and Customer Support Scientist
26.10.2020
We are hiring. Apply by 8th of November 2020.
-
Influenza or COVID-19? Reliable diagnosis in 75 minutes with new multiplex assay
23.9.2020
-
GenomEra SARS-CoV-2 Assay Kit is now CE IVD approved and development for four-in-one test (FluA, FluB, RSV, SARS-CoV-2) is on-going
17.7.2020
GenomEra SARS-CoV-2 Assay Kit is now CE IVD approved and available. Please contact your local distributor or us for more information.
In addition, we are developing a four-in-one test for detecting influenza A, influenza B, RSV and SARS-CoV-2. Targeted release is before winter Flu season 2020-2021. -
Special approval granted for SARS-CoV-2 test
4.5.2020
Finnish regulatory authority Fimea has granted special approval for Abacus to supply the GenomEra RUO SARS-CoV-2 test to Finnish markets.
Press release in Finnish -
First SARS-CoV-2 Test Kits Shipped
30.3.2020
Our team has been working hard on past weeks and today we shipped first GenomEra SARS-CoV-2 test kits for our customers.
Press-release in Finnish: https://bit.ly/2UvaMC2
-
Recent publication: GenomEra C. difficile test demonstrates increased reliability for standalone molecular diagnostics
11.3.2020
While covid19 is spreading, there are still other worries to deal with. Standalone PCR testing for C. difficile diagnostics is often criticized for overdiagnosis of CDI. In a recent publication (doi:10.1128/JCM.01872-19) GenomEra routine samples were retested with two different toxin immunoassays and discrepant results were confirmed with culture or GeneXpert. Results shows perfect 100% PPV and excellent 99.7% NPV for GenomEra. Study reports insufficient sensitivities of 81.6% and 71.7% for two different toxin immunoassay from ArcDia and TechLab, respectively.
-
Announcement of a new distributor
28.1.2020
We are proud to announce our new distributor:
-NexGen Molecular Supplies, South Africa.
Please visit https://www.abacusdiagnostica.com/distributors/ to view the complete list. #pcr #abacusdiagnostica #molecular #diagnostics